Table 4 Laboratory Examination-related prognosis predictors of patients with GBS
From: Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review
Number of patients(%) | MRC score at discharge | Comparison* (P-value) | |
|---|---|---|---|
Serum sodium concentration | 0.020* | ||
Low | 24 (21.62%) | 28.57±12.73 | |
Normal | 85 (76.58%) | 34.93±8.34 | |
Fasting glucose level | 0.028* | ||
High | 27 (24.32%) | 27.15±14.136 | |
Normal | 78 (70.27%) | 35.74±6.689 | |
Serum albumin level | 0.005* | ||
Normal | 55 (49.55%) | 36.69±5.231 | |
Low | 54 (48.65%) | 30.34±12.075 | |
White blood cell count | 0.010* | ||
Low | 8 (7.21%) | 36.00±7.303 | |
Normal | 76 (68.47%) | 35.03±7.806 | |
High | 23 (20.72%) | 26.25±14.435 | |
Hepatic function | 0.048* | ||
Elevated ALT/AST level | 32 (28.83%) | 29.52±12.630 | |
Normal ALT&AST level | 78(70.27%) | 34.73±8.719 | |
Renal function | 0.009* | ||
Elevated BUN/Scr level Normal BUN&Scr level | 22 (19.82%) 88 (79.28%) | 28.86±11.521 34.39±9.657 | |
Plasma fibrinogen | 0.001* | ||
High | 23 (20.72%) | 26.35±13.533 | |
Normal | 59 (53.15%) | 35.16±8.875 |